Loading…
Guardian Pharmacy Services, Inc. is projected to rise to $58.60 by 2027, a +50% move from its current price of $39.12. GRDN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $38.53 | $39.14 | $39.77 | +0.06% |
| May 30 | $38.30 | $39.16 | $40.05 | +0.11% |
| May 31 | $38.13 | $39.19 | $40.27 | +0.17% |
| Jun 1 | $37.99 | $39.21 | $40.47 | +0.22% |
| Jun 2 | $37.87 | $39.23 | $40.64 | +0.28% |
| Jun 3 | $37.76 | $39.25 | $40.80 | +0.34% |
| Jun 4 | $37.67 | $39.27 | $40.95 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.67 | $39.27 | $40.95 | +0.39% |
| Week 2 | $37.16 | $39.43 | $41.83 | +0.79% |
| Week 3 | $36.82 | $39.58 | $42.55 | +1.18% |
| Week 4 | $36.55 | $39.74 | $43.20 | +1.58% |
| Week 5 | $36.33 | $39.89 | $43.80 | +1.98% |
| Week 6 | $36.15 | $40.05 | $44.37 | +2.38% |
| Week 7 | $36.00 | $40.21 | $44.91 | +2.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Guardian Pharmacy Services, Inc. is a healthcare company that provides technology-enabled pharmacy services to residents of long-term health care facilities (LTCFs) in the United States. Its scope includes individualized clinical, drug dispensing, and administration capabilities to residents in lower acuity LTCFs such as assisted living facilities, behavioral health facilities, and group homes.
Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
GRDN is a Healthcare stock with current price $38.48 and market cap $2.44B. It is ranked 1874 among tradable assets by market capitalization.
The asset operates within the Healthcare category, and the price outlook is described through a multi-year forecast. In 2026, the average price is $38.48 with neutral sentiment; subsequent years show a clear bullish trajectory, culminating in a long-run average of $790.67 (2050) with a max of $1,293.87 and a strong long-term upside.
A major floor 30.9% below — a decisive break under it would weaken the trend.
The nearest floor, 10.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 7.2% above — clearing it would confirm fresh momentum.
Key GRDN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GRDN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.44 | Buy | $38.34 | Buy |
| MA 10 | $37.28 | Buy | $37.70 | Buy |
| MA 20 | $36.91 | Buy | $37.27 | Buy |
| MA 50 | $37.08 | Buy | $36.48 | Buy |
| MA 100 | $34.53 | Buy | $34.72 | Buy |
| MA 200 | $31.06 | Buy | $31.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.78 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 159.01 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.32 | Buy |
| ROC (12) | 8.40 | Buy |
| Bollinger %B (20,2) | 1.00 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 1.19 | Buy |
| Ultimate (7,14,28) | 73.46 | Sell |
| Momentum (10) | 4.21 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 39.31 | Sell |
| ADX (14) | 13.34 | Neutral |
| ATR (14) | 0.56 | Info |
The 30-day technical picture is bullish overall, supported by an RSI14 of 60 and trend-following moving averages. The SMA50 is $36.83 and the SMA200 is $30.87, signaling positive near-term momentum.
Key near-term levels include support at $34.91 and resistance at $39.49, with a 30-day trading range from $34.49 to $42.94.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.03 | $39.12 | $57.13 | 0% | Neutral | |
| $47.87 | $58.60 | $75.08 | +50% | Bullish | |
| $56.41 | $70.31 | $92.45 | +80% | Bullish | |
| $61.93 | $78.36 | $105.17 | +100% | Bullish | |
| $72.93 | $93.51 | $127.72 | +139% | Bullish | |
| $89.27 | $115.84 | $160.69 | +196% | Bullish | |
| $110.16 | $144.55 | $203.34 | +270% | Bullish | |
| $129.92 | $172.26 | $245.42 | +340% | Bullish | |
| $136.21 | $182.38 | $262.91 | +366% | Bullish | |
| $149.49 | $202.06 | $294.49 | +417% | Bullish | |
| $260.18 | $366.72 | $559.95 | +837% | Bullish | |
| $561.44 | $848.57 | $1,388.49 | +20.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $27.03 | $39.12 | $46.06 | +0.00% |
| June 2026 | $35.10 | $40.95 | $48.69 | +4.67% |
| July 2026 | $35.09 | $41.17 | $49.42 | +0.54% |
| August 2026 | $35.54 | $41.88 | $50.64 | +1.74% |
| September 2026 | $36.82 | $43.56 | $52.99 | +4.00% |
| October 2026 | $37.32 | $44.30 | $54.17 | +1.69% |
| November 2026 | $37.36 | $44.48 | $54.65 | +0.40% |
| December 2026 | $38.77 | $46.29 | $57.13 | +4.08% |
Click any year to see its month-by-month GRDN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Guardian Pharmacy Services, Inc.'s 2026 outlook centres on $39.12, within a $27.03 to $57.13 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GRDN could reach as high as $75.08, with a base case around $58.60 and support toward $47.87 — roughly +50% from $39.12. Buyers look set to stay in control over this stretch.
Expect GRDN to range from $56.41 to $92.45 through 2028. The $70.31 average target implies a +80% move from current prices. That is up +20% on the projected 2027 average. Momentum favours further upside here.
The GRDN price prediction for 2029 points to an average of $78.36 (low $61.93, high $105.17) — a potential gain of +100% on today's $39.12. Buyers look set to stay in control over this stretch.
In 2030, GRDN is projected to trade between $72.93 and $127.72, averaging $93.51 — a potential gain of +139% from today's $39.12. That is up +19% on the projected 2029 average. Momentum favours further upside here.
Guardian Pharmacy Services, Inc.'s 2031 outlook centres on $115.84, within a $89.27 to $160.69 range. That is up +24% on the projected 2030 average. That marks a +196% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GRDN could reach as high as $203.34, with a base case around $144.55 and support toward $110.16 — roughly +270% from $39.12. Momentum favours further upside here.
Expect GRDN to range from $129.92 to $245.42 through 2033. The $172.26 average target implies a +340% move from current prices. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GRDN price prediction for 2034 points to an average of $182.38 (low $136.21, high $262.91) — a potential gain of +366% on today's $39.12. Momentum favours further upside here.
In 2035, GRDN is projected to trade between $149.49 and $294.49, averaging $202.06 — a potential gain of +417% from today's $39.12. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Guardian Pharmacy Services, Inc.'s 2040 outlook centres on $366.72, within a $260.18 to $559.95 range. That is up +81% on the projected 2035 average. That marks a +837% change versus current levels. Momentum favours further upside here.
By 2050, GRDN could reach as high as $1,388.49, with a base case around $848.57 and support toward $561.44 — roughly +20.7x from $39.12. Buyers look set to stay in control over this stretch.
Investing $1,000 in GRDN today (≈ 25.562372 GRDN) could be worth
$21,691.48
+$20,691.48 (+2069%) by 2050 · US Dollar
Based on the average projected GRDN price of $848.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GRDNwould be worth at today's price.
$1,000 invested in GRDN on May 27, 2025 (≈ 45.18753 GRDN) would be worth
$1,767.74
+$767.74 (+76.8%) today · 1.77× · US Dollar
Based on a GRDN entry price of $22.13 vs. today's $39.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $37.63 | $1,039.6 | +4.0% |
| 1 month ago | $37.93 | $1,031.37 | +3.1% |
| 3 months ago | $33.07 | $1,182.95 | +18.3% |
| 6 months ago | $29.28 | $1,336.07 | +33.6% |
| 1 year ago | $22.13 | $1,767.74 | +76.8% |
| All time (1.7y) ago | $16 | $2,445 | +144.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GRDN forecast.
Our base-case forecast reaches $78.00 around 2029.
Implied market cap at $78.00: $3.88B
The multi-year forecast shows substantial upside across the horizon. In 2030 the stock is forecast to average $90.06 with a min of $70.23 and a max of $123.04, delivering an ROI of 134.1 and a bullish sentiment. By 2040, the average is projected at $344.07 (min $244.08, max $525.43) with an ROI of 794.1 and a bullish stance.
Looking further to 2050, the forecast envisions an average of $790.67 (min $523.09, max $1,293.87) and an ROI of 1954.8, still with a bullish sentiment. These are estimates and not guarantees and depend on market conditions and other factors. The range of outcomes illustrates meaningful upside potential alongside inherent investment risk.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $90.06, with a min of $70.23 and a max of $123.04, and an ROI of 134.1%; sentiment is BULLISH.
Forecasts indicate neutral for 2026, then bullish from 2027 onward, with 2027 average $57.46 (ROI 49.3%) and 2050 average $790.67 (ROI 1954.8%), suggesting upside but with uncertainty.
Yes, the 2050 forecast max is $1,293.87, indicating the potential to exceed $1,000, though these are not guarantees and depend on market conditions.
Bullish sentiment with RSI14 at 60. The SMA50 is $36.83 and the SMA200 is $30.87, with near-term support at $34.91 and resistance at $39.49, and a 30-day range of $34.49 to $42.94.
Current price is $38.48 and market cap is $2.44B; the stock is ranked 1874 in market capitalization.
Guardian Pharmacy Services, Inc. Community Discussion
0Share your Guardian Pharmacy Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.